7306-17-4 Usage
Derivative of acetic acid
2-(1-Phenylcyclobutyl)acetic acid is derived from acetic acid, which means it has a similar structure and properties to acetic acid.
Contains a cyclobutyl and a phenyl group
2-(1-Phenylcyclobutyl)acetic acid has a cyclobutyl and a phenyl group attached to the carbon atom, which gives it unique chemical and physical properties.
Potential pharmaceutical applications
2-(1-Phenylcyclobutyl)acetic acid has been studied for its potential use in the pharmaceutical industry, particularly as a non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties.
Possible treatment for neurodegenerative disorders
2-(1-Phenylcyclobutyl)acetic acid may have potential use in the treatment of neurodegenerative disorders, such as Alzheimer's disease or Parkinson's disease.
Anticonvulsant properties
2-(1-Phenylcyclobutyl)acetic acid may also have potential use as an anticonvulsant, which can help prevent or treat seizures.
Further research needed
Further research is needed to fully understand the pharmacological properties and potential therapeutic applications of 2-(1-Phenylcyclobutyl)acetic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 7306-17-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,0 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 7306-17:
(6*7)+(5*3)+(4*0)+(3*6)+(2*1)+(1*7)=84
84 % 10 = 4
So 7306-17-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H14O2/c13-11(14)9-12(7-4-8-12)10-5-2-1-3-6-10/h1-3,5-6H,4,7-9H2,(H,13,14)
7306-17-4Relevant academic research and scientific papers
5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE
-
Page/Page column 140, (2017/02/28)
Provided in some embodiments are compounds of Formula A, as defined herein, that modulate the activity of 5-HT2C receptor. Also provided in some embodiments are methods, such as, for weight management, inducing satiety, and decreasing food intake, and for
NOVEL TRPV3 MODULATORS
-
Paragraph 0472, (2013/06/27)
Disclosed herein are modulators of TRPV3 of formula (I) wherein G1, X1, X2, X3, X4, X5, G2, Z1, Ra, Rb, u, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
NOVEL TRPV3 MODULATORS
-
Page/Page column 88-89, (2012/03/09)
Disclosed herein are modulators of TRPV3 of formula (I), wherein G1, X1, X2, X3, X4, X5, G2, Z1, Ra, Rb, u, and p are as defined in the specifica
